Asklepion Pharmaceuticals
OverviewSuggest Edit
Asklepion Pharmaceuticals is a biopharmaceutical company specializing in rare pediatric diseases. It focuses on the discovery, development, and commercialization of pharmaceutical products for acute lung injury induced by cardiopulmonary bypass and acute sickle cell crisis.
| Type | Private | |
| Founded | 2006 | |
| HQ | Baltimore, US | Map |
| Website | asklepionpharm.com |
Locations
Latest Updates
| Employees (est.) (Mar 2020) | 9 |
Asklepion Pharmaceuticals Office Locations
Asklepion Pharmaceuticals Financials and Metrics
Summary Metrics
Founding Date | 2006 |
Asklepion Pharmaceuticals Online and Social Media Presence
Asklepion Pharmaceuticals's Trends
Asklepion Pharmaceuticals Frequently Asked Questions
When was Asklepion Pharmaceuticals founded?
Asklepion Pharmaceuticals was founded in 2006.
How many employees does Asklepion Pharmaceuticals have?
Asklepion Pharmaceuticals has 9 employees.
Who are Asklepion Pharmaceuticals competitors?
Competitors of Asklepion Pharmaceuticals include Regulus Therapeutics, BioMarin Pharmaceutical and PTC Therapeutics.
Where is Asklepion Pharmaceuticals headquarters?
Asklepion Pharmaceuticals headquarters is located at 729 E Pratt St #360, Baltimore.
Where are Asklepion Pharmaceuticals offices?
Asklepion Pharmaceuticals has an office in Baltimore.
How many offices does Asklepion Pharmaceuticals have?
Asklepion Pharmaceuticals has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies